Fundraising FoxVentura BioMed Investors
Venture capitalMunich · Seed–Series A · 2 people tracked
Find your way into Ventura BioMed Investors
Sign up to see every warm intro you have to Ventura BioMed Investors
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ventura BioMed Investors team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Ventura BioMed Investors focuses on early-stage life science companies developing pioneering technologies and innovative therapies. It typically invests EUR 1-5 million per company, always co-investing in consortia with other funds and within Europe. The firm can further expand its reach through Ventura Ace, an investment platform of selected private investors. Led by serial biotech and pharmaceutical entrepreneurs, the firm helps shape the long-term development of its portfolio companies and provides them with access to a broad investor and business network to accelerate medical breakthroughs.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's website & public directories
What they invest in
from 5 of 5 portfolio companiesBiotech ×5Healthtech ×3Medical Devices ×3Deep Tech ×2AI & Machine Learning ×1Digital Health ×1
HQs:Germany×3United States×1
Investments · 5 tracked
founders shown can be your intro path
Kupando is a biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases.
AI & Machine LearningBiotechMedical DevicesSchönefeld, DE
Johanna Holldack(CEO)in
BoardPierre Morgon(Chairman)Wolfram Nothaft(Deputy Chairman)
Co-investorsBrandenburg KapitalRemiges Ventures, Inc.CARMA FUND
Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer.
BiotechHealthtech
Co-investorscoparionApollo Health VenturesBoehringer Ingelheim Venture Fund
Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics.
BiotechDeep TechMedical Devices
Simon RestrepoinKaspar BinzinScott Fraserin
Co-investorsZEISS Ventures
iQure Pharma is a biopharmaceutical company developing therapies aimed at restoring glutamate balance and reducing excitotoxicity in neurological disorders with high unmet need.
BiotechHealthtechSkillman, US
Peter Schiemann(Founder)inPawel Zolnierczyk(Executive Officer)in
Co-investorsi&i Biotech FundKeiretsu Forum
TQ Therapeutics develops cell and gene therapy technologies and processes to make challenging diseases curable.
BiotechDeep TechDigital HealthHealthtechMedical DevicesPlanegg, DE
Dr. Christian Eckert(Chief Executive Officer & Co-Founder)Dr. Christian Stemberger(Chief Scientific Officer & Co-Founder)Sabine Radisch(Chief Technology Officer & Co-Founder)inDr. Stefan Dreher(Chief Operating Officer & Co-Founder)
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Ventura BioMed Investors made?
- Ventura BioMed Investors has 5 tracked investments.
- What stage does Ventura BioMed Investors invest at?
- Ventura BioMed Investors invests at the Seed, Series A stages.
- What is Ventura BioMed Investors's typical check size?
- Ventura BioMed Investors typically writes checks of $1.1M – $5.5M.
- What sectors does Ventura BioMed Investors focus on?
- Ventura BioMed Investors focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Ventura BioMed Investors located?
- Ventura BioMed Investors is headquartered in Munich, DE.
- Does Ventura BioMed Investors lead rounds?
- Ventura BioMed Investors typically participates in rounds rather than leading them.
- Who does Ventura BioMed Investors co-invest with?
- Ventura BioMed Investors most often shares deals with Brandenburg Kapital, CARMA FUND, coparion, among 7 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.